Who are AstronauTX Ltd's investors?

AstronauTX Ltd's investors include Dementia Discovery Fund, MPM BioImpact, Novartis Venture Fund, SV Health Investors, UCL Technology Fund, AlbionVC.

AstronauTX Ltd

Founded 2019 · 26 employees on LinkedIn · 6 known investors

Find your way into AstronauTX Ltd

Each arrow is one introduction. Sign up to fill in the first one.

338 people can intro you to Jane

Ask David Anderson to introduce you to Jane Rhodes

You →David · together at Qr8 Health →Jane

177 people can intro you to Michelle

Ask Jamie Chen to introduce you to Michelle L. Mellion

You →Jamie · together at PepGen →Michelle

Your email: who you already know at AstronauTX Ltd, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AstronauTX Ltd team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics. Its programs target areas such as Alzheimer's disease, sleep, and other CNS disorders.

Biotech Deep Tech Healthtech Longevity Medical Devices

Founders & leadership

Jane Rhodes Chief Executive OfficerJane Rhodes is a neuroscientist and CEO of AstronauTx, a biotechnology company developing drug candidates for neurodegenerative and neuroinflammatory diseases.

Magnus IvarssonChief Scientific OfficerChief Scientific Officer at 0 2 AstronauTx

Hannah PearceChief Operating OfficerChief Operating Officer at 0 2 AstronauTx

Michelle L. Mellion Chief Medical OfficerMichelle L. Mellion is a board-certified neurologist and clinical neurophysiologist with over 20 years of experience in clinical care, research, and drug development across biotech. She trained at Wake Forest University School of Medicine and Brown University, served as Neurology Residency Program Director and Clinical Neurophysiology Fellowship Director at Brown, and has led early- and late-phase clinical trial programs in CNS disorders including neurodegeneration and neuromuscular disease.

Investors · 6

Dementia Discovery Fundlisted by Dementia Discovery FundLondon

How we know: Dementia Discovery Fund's portfolio page · Not right? Tell us

MPM BioImpactlisted by MPM BioImpactBoston · $1M – $15M

How we know: MPM BioImpact's portfolio page · Not right? Tell us

Novartis Venture Fundlisted by Novartis Venture FundBasel · $5M – $25M

How we know: Novartis Venture Fund's portfolio page · a partner's Signal profile · Not right? Tell us

SV Health Investorslisted by SV Health InvestorsLondon · $1M – $20M

How we know: SV Health Investors's portfolio page · Not right? Tell us

UCL Technology Fundlisted by UCL Technology FundLondon · $320K – $9M

AlbionVCreportedLondon

How we know: a partner's Signal profile · Not right? Tell us

Frequently asked questions

What does AstronauTX Ltd do?: AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics. Its programs target areas such as Alzheimer's disease, sleep, and other CNS disorders.
Who are AstronauTX Ltd's investors?: AstronauTX Ltd's investors include Dementia Discovery Fund, MPM BioImpact, Novartis Venture Fund, SV Health Investors, UCL Technology Fund, AlbionVC.